Concord Biotech Limited IPO

Concord Biotech Limited is listed in the MAINBOARD segment with a price band of ₹705 to ₹741. The figures below are as reported by the exchanges and public sources.

Concord Biotech Limited IPO — key facts

• The Concord Biotech Limited IPO price band is ₹705 to ₹741 per share.
• As of 5 September 2026, the Concord Biotech Limited IPO subscription status is 24.87x overall.
• The issue is open from 04-AUG-2023 to 08-AUG-2023.
• Concord Biotech Limited listed on 18-AUG-2023.
• Concord Biotech Limited listed at ₹941.85. The listing gain was 27.1% against the upper end of the issue price band.

Concord Biotech Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹705 – ₹741

Issue size

₹1550.52 Cr

Offer for sale

₹1550.52 Cr

Opens

04-AUG-2023

Closes

08-AUG-2023

Listing

18-AUG-2023

Total subscription

24.87x

Retail

3.78x

QIB

67.67x

NII

16.99x

Lead managers

Kotak Mahindra Capital (left lead)

Listing price

₹941.85

Listing day change

+27.1%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.